Skip to main content
PMC home page
Japanese Journal of Cancer Research : Gann logoLink to Japanese Journal of Cancer Research : Gann
. 1990 Oct;81(10):967–970. doi: 10.1111/j.1349-7006.1990.tb03332.x

Alloimmunization with Cultured Human Stomach Cancer Cell Lines and the Establishment of Human‐Human Hybridomas Producing Monoclonal Antibodies

Kotaro Koyama 1, Koichi Akiyama 2, Hiroharu Kawahara 2, Akira Egashira 3, Hiroki Murakami 3
PMCID: PMC5917964  PMID: 2121682

Abstract

Alloimmunization with the cultured human stomach cancer cell lines MKN‐45 and MKN‐28 was conducted and human‐human hybridomas were established. Living MKN‐45 cells (107 cells per injection) were injected monthly 34 times into one of the authors (K.K.) over 2 years and living MKN‐28 cells (107 cells per injection) were co‐injected 14 times after the 20th injection of MKN‐45 alone. Cultured stomach cancer cells injected subcutaneously into K.K.'s forearm were rejected completely, although they grew transiently at the injection site. All the injections were made voluntarily at the direction of K.K. himself. Two human‐human hybridomas producing monoclonal antibodies reactive with MKN‐45 and MKN‐28 cells, respectively, were separated from a hybridoma of human B‐lymphoblastoid cell line named HO 323/WIL2‐NS and lymphocytes in K.K.'s peripheral blood. One cell line of the hybridoma FMK‐H3 produced IgM‐type monoclonal antibody, and the other line, EMK‐F7, produced IgG‐type antibody. These two human‐human monoclonal antibodies were highly reactive with MKN‐45 and MKN‐28 cells, weakly reactive with MKN‐74 stomach cancer cell line, and not reactive with the other stomach cancer cell lines tested (MKN‐1, MKN‐7, TMK‐1, NUGU‐2, NUGC‐3, NUGC‐4 and KATO‐III).

Keywords: Human monoclonal antibody, Human stomach cancer cell line, Alloimmunization

Full Text

The Full Text of this article is available as a PDF (597.3 KB).

References

  • 1.Olsson, L. and Kaplan, H. S.Human‐human hybridomas producing monoclonal antibodies of predefined specificity. Proc. Natl. Acad. Sci. USA, 77, 5427–5431 (1980). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Sikora, K., Alderson, T., Phillips, J. and Watson, J.Human hybridomas from patients with malignant disease. Br. J. Cancer, 47, 135–145 (1983). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Glassy, M. C., Handley, H. H., Hagiwara, H. and Royston, I.UC729‐6, a human lymphoblastoid B‐cell line useful for generating antibody‐secreting human‐human hybridomas. Proc. Natl. Acad. Sci. USA, 80, 5429–5431 (1980). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Murakami, H., Hashizume, S., Ohashi, H., Shinohara, K., Yasumoto, K., Nomoto, K. and Omura, H.Human‐human hybridomas secreting antibodies specific to human lung carcinoma. In vitro Cell. Dev. Biol., 21, 593–596 (1985). [DOI] [PubMed] [Google Scholar]
  • 5.Irie, R. F., Matsuki, T. and Morton, D. L.Human monoclonal antibody to ganglioside GM2 for melanoma treatment. Lancet, i, 786–787 (1989). [DOI] [PubMed] [Google Scholar]
  • 6.Hojo, H. and Oboshi, S.Establishment of cultured cell lines of human stomach cancer origin and their morphological characteristics. Niigata Med. J., 91, 737–763 (1977) (in Japanese). [Google Scholar]
  • 7.Ohashi, H., Hashizume, S., Murakami, H., Aihara, K., Shinohara, K. and Omura, H.HO‐323, a human B‐lymphoblastoid cell line useful for making human‐human hybridomas. Cell Biol. Int. Rep., 10, 77–83 (1986). [DOI] [PubMed] [Google Scholar]
  • 8.Houghton, A. N., Brooks, H., Cote, R. J., Taormina, M. C., Oettgen, H. F. and Old, L. J.Detection of cell surface and intracellular antigens by human monoclonal antibodies. J. Exp. Med., 158, 53–65 (1983). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Ochiai, A., Yasui, W. and Tahara, E.Growth‐promoting effect of gastrin on human gastric carcinoma cell line TMK‐1. Jpn. J. Cancer Res., 76, 1064–1071 (1985). [PubMed] [Google Scholar]
  • 10.Uchida, T., Hirabayashi, Y., Watanabe, T. and Kondo, T.Analysis of cell surface antigen of gastric cancer by autologous typing. Clin. Immunol., 17, 858–868 (1985) (in Japanese). [Google Scholar]
  • 11.Sekiguchi, M., Sakakibara, K. and Fujii, G.Establishment of culture cell lines derived from a human gastric carcinoma. Jpn. J. Exp. Med., 48, 61–68 (1978). [PubMed] [Google Scholar]
  • 12.Koyama, K., Nudelman, E., Fukuda, M. and Hakomori, S.Correlation of glycosylation in a membrane protein with a molecular weight of 150,000 with tumorigenic property of rat fibrosarcoma variants. Cancer Res., 39, 3677–3682 (1979). [PubMed] [Google Scholar]
  • 13.Koyama, K., Tamayama, C., Tomono, Y. and Watanabe, K.Glycosphingolipids in clonal variants of rat fibrosarcoma cells with different transplantability. Gann, 74, 517–523 (1983). [PubMed] [Google Scholar]
  • 14.Hakomori, S. and Kannagi, R.Glycosphingolipid as tumor‐associated and differentiation markers. J. Natl. Cancer Inst., 71, 231–251 (1983). [PubMed] [Google Scholar]
  • 15.Hakomori, S., Nudelman, E., Levery, S. B. and Patterson, C. M.Human cancer‐associated gangliosides defined by a monoclonal antibody (IB9) directed to sialosyl 2–6 galactosyl residue: a preliminary note. Biochem. Biophys. Res. Commun., 113, 791–798 (1983). [DOI] [PubMed] [Google Scholar]
  • 16.Tai, T., Paulson, J. C. and Irie, R. F.Ganglioside GM2 as a tumor antigen (OFA‐1). Proc. Natl. Acad. Sci. USA, 80, 5392–5396 (1983). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Carubia, J. M., Yu, R. K., Macala, L. J., Kirkwood, J. M. and Varga, J. M.Gangliosides of normal and neoplastic melanocytes. Biochem. Biophys. Res. Commun., 120, 500–504 (1984). [DOI] [PubMed] [Google Scholar]

Articles from Japanese Journal of Cancer Research : Gann are provided here courtesy of Wiley

RESOURCES